Zoetis Inc has a consensus price target of $212.43 based on the ratings of 14 analysts. The high is $244 issued by Barclays on February 14, 2025. The low is $165 issued by Stifel on April 14, 2025. The 3 most-recent analyst ratings were released by Stifel, Piper Sandler, and Barclays on April 14, 2025, February 27, 2025, and February 14, 2025, respectively. With an average price target of $204.67 between Stifel, Piper Sandler, and Barclays, there's an implied 39.46% upside for Zoetis Inc from these most-recent analyst ratings.
1calculated from analyst ratings
Buy Now | Get Alert | |||||||
---|---|---|---|---|---|---|---|---|
04/14/2025 | Buy Now | 12.43% | Stifel | Jonathan Block71% | $180 → $165 | Maintains | Buy | Get Alert |
02/27/2025 | Buy Now | 39.68% | Piper Sandler | David Westenberg59% | $200 → $205 | Maintains | Overweight | Get Alert |
02/14/2025 | Buy Now | 66.26% | Barclays | Balaji Prasad51% | $242 → $244 | Maintains | Overweight | Get Alert |
02/14/2025 | Buy Now | 62.17% | Morgan Stanley | Erin Wright76% | $243 → $238 | Maintains | Overweight | Get Alert |
02/10/2025 | Buy Now | 36.28% | Piper Sandler | David Westenberg59% | $210 → $200 | Maintains | Overweight | Get Alert |
01/29/2025 | Buy Now | 65.58% | Morgan Stanley | Erin Wright76% | $248 → $243 | Maintains | Overweight | Get Alert |
01/07/2025 | Buy Now | 22.65% | Stifel | Jonathan Block71% | $210 → $180 | Maintains | Buy | Get Alert |
12/09/2024 | Buy Now | 33.55% | UBS | — | → $196 | Initiates | → Neutral | Get Alert |
12/02/2024 | Buy Now | 46.5% | Leerink Partners | Daniel Clark13% | → $215 | Initiates | → Outperform | Get Alert |
10/11/2024 | Buy Now | 56.72% | JP Morgan | Chris Schott59% | $225 → $230 | Maintains | Overweight | Get Alert |
09/18/2024 | Buy Now | 43.09% | Stifel | Jonathan Block71% | $200 → $210 | Maintains | Buy | Get Alert |
08/27/2024 | Buy Now | 36.28% | Stifel | Jonathan Block71% | $200 → $200 | Maintains | Buy | Get Alert |
08/14/2024 | Buy Now | 43.09% | Piper Sandler | David Westenberg59% | $195 → $210 | Maintains | Overweight | Get Alert |
08/12/2024 | Buy Now | 53.31% | BTIG | Mark Massaro72% | $220 → $225 | Maintains | Buy | Get Alert |
08/07/2024 | Buy Now | 64.9% | Barclays | Balaji Prasad51% | $230 → $242 | Maintains | Overweight | Get Alert |
08/05/2024 | Buy Now | 36.28% | Stifel | Jonathan Block71% | $180 → $200 | Maintains | Buy | Get Alert |
07/25/2024 | Buy Now | 49.9% | BTIG | Mark Massaro72% | → $220 | Initiates | → Buy | Get Alert |
05/08/2024 | Buy Now | 53.31% | HSBC | Morten Herholdt37% | $230 → $225 | Maintains | Buy | Get Alert |
05/06/2024 | Buy Now | 33.55% | Goldman Sachs | Nathan Rich43% | $223 → $196 | Maintains | Buy | Get Alert |
04/30/2024 | Buy Now | 22.65% | Stifel | Jonathan Block71% | $195 → $180 | Maintains | Buy | Get Alert |
04/23/2024 | Buy Now | 56.72% | Barclays | Balaji Prasad51% | $260 → $230 | Maintains | Overweight | Get Alert |
04/16/2024 | Buy Now | 32.87% | Piper Sandler | David Westenberg59% | $220 → $195 | Reiterates | Overweight → Overweight | Get Alert |
04/02/2024 | Buy Now | 32.87% | Stifel | Jonathan Block71% | $215 → $195 | Maintains | Buy | Get Alert |
02/20/2024 | Buy Now | 49.9% | Piper Sandler | David Westenberg59% | $215 → $220 | Maintains | Overweight | Get Alert |
02/14/2024 | Buy Now | 77.16% | Barclays | Balaji Prasad51% | $255 → $260 | Maintains | Overweight | Get Alert |
01/17/2024 | Buy Now | 53.99% | Goldman Sachs | Nathan Rich43% | $190 → $226 | Maintains | Buy | Get Alert |
12/19/2023 | Buy Now | 56.72% | Jefferies | Glen Santangelo50% | → $230 | Assumes | → Buy | Get Alert |
11/06/2023 | Buy Now | 46.5% | Piper Sandler | David Westenberg59% | $210 → $215 | Maintains | Overweight | Get Alert |
10/30/2023 | Buy Now | 32.87% | Stifel | Jonathan Block71% | $205 → $195 | Maintains | Buy | Get Alert |
09/12/2023 | Buy Now | 39.68% | Stifel | Jonathan Block71% | → $205 | Reiterates | Buy → Buy | Get Alert |
09/06/2023 | Buy Now | 56.72% | HSBC | Morten Herholdt37% | → $230 | Initiates | → Buy | Get Alert |
08/28/2023 | Buy Now | 39.68% | Stifel | Jonathan Block71% | $195 → $205 | Maintains | Buy | Get Alert |
08/14/2023 | Buy Now | 49.9% | Piper Sandler | David Westenberg59% | $210 → $220 | Maintains | Overweight | Get Alert |
08/10/2023 | Buy Now | 45.13% | Goldman Sachs | Nathan Rich43% | $204 → $213 | Maintains | Buy | Get Alert |
06/14/2023 | Buy Now | 53.31% | Atlantic Equities | Steve Chesney56% | → $225 | Reiterates | Overweight → Overweight | Get Alert |
05/26/2023 | Buy Now | 53.31% | Atlantic Equities | Steve Chesney56% | → $225 | Reiterates | Overweight → Overweight | Get Alert |
05/08/2023 | Buy Now | 43.09% | Piper Sandler | David Westenberg59% | $220 → $210 | Maintains | Overweight | Get Alert |
02/21/2023 | Buy Now | 77.16% | Barclays | Balaji Prasad51% | $250 → $260 | Maintains | Overweight | Get Alert |
11/15/2022 | Buy Now | 68.98% | Morgan Stanley | Erin Wright76% | $264 → $248 | Maintains | Overweight | Get Alert |
11/04/2022 | Buy Now | 22.65% | B of A Securities | Michael Ryskin46% | $225 → $180 | Maintains | Buy | Get Alert |
11/04/2022 | Buy Now | 22.65% | Goldman Sachs | Nathan Rich43% | $207 → $180 | Maintains | Buy | Get Alert |
10/17/2022 | Buy Now | 53.31% | JP Morgan | Chris Schott59% | $250 → $225 | Maintains | Overweight | Get Alert |
07/21/2022 | Buy Now | 37.64% | Goldman Sachs | Nathan Rich43% | $208 → $202 | Maintains | Buy | Get Alert |
07/12/2022 | Buy Now | 39.68% | Piper Sandler | David Westenberg59% | → $205 | Initiates | → Overweight | Get Alert |
06/29/2022 | Buy Now | 53.31% | Stifel | Jonathan Block71% | $225 → $225 | Maintains | Buy | Get Alert |
06/24/2022 | Buy Now | 53.31% | Stifel | Jonathan Block71% | $275 → $225 | Maintains | Buy | Get Alert |
06/17/2022 | Buy Now | 36.28% | Argus Research | Jasper Hellweg69% | $225 → $200 | Maintains | Buy | Get Alert |
05/19/2022 | Buy Now | 41.73% | Goldman Sachs | Nathan Rich43% | $237 → $208 | Maintains | Buy | Get Alert |
The latest price target for Zoetis (NYSE:ZTS) was reported by Stifel on April 14, 2025. The analyst firm set a price target for $165.00 expecting ZTS to rise to within 12 months (a possible 12.43% upside). 21 analyst firms have reported ratings in the last year.
The latest analyst rating for Zoetis (NYSE:ZTS) was provided by Stifel, and Zoetis maintained their buy rating.
There is no last upgrade for Zoetis
There is no last downgrade for Zoetis.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Zoetis, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Zoetis was filed on April 14, 2025 so you should expect the next rating to be made available sometime around April 14, 2026.
While ratings are subjective and will change, the latest Zoetis (ZTS) rating was a maintained with a price target of $180.00 to $165.00. The current price Zoetis (ZTS) is trading at is $146.76, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.